Multiple paradoxical reactions during ixekizumab therapy
Federico Pirro
Institute of Dermatology, Catholic University—Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Search for more papers by this authorGiacomo Caldarola
Institute of Dermatology, Catholic University—Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Search for more papers by this authorCorresponding Author
Clara De Simone
Institute of Dermatology, Catholic University—Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Correspondence
Clara De Simone, Institute of Dermatology, Catholic University—Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go F. Vito 1, Rome 00135, Italy.
Email: [email protected]
Search for more papers by this authorGaia Moretta
Institute of Dermatology, Catholic University—Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Search for more papers by this authorGiulia Giovanardi
Institute of Dermatology, Catholic University—Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Search for more papers by this authorKetty Peris
Institute of Dermatology, Catholic University—Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Search for more papers by this authorFederico Pirro
Institute of Dermatology, Catholic University—Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Search for more papers by this authorGiacomo Caldarola
Institute of Dermatology, Catholic University—Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Search for more papers by this authorCorresponding Author
Clara De Simone
Institute of Dermatology, Catholic University—Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Correspondence
Clara De Simone, Institute of Dermatology, Catholic University—Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go F. Vito 1, Rome 00135, Italy.
Email: [email protected]
Search for more papers by this authorGaia Moretta
Institute of Dermatology, Catholic University—Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Search for more papers by this authorGiulia Giovanardi
Institute of Dermatology, Catholic University—Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Search for more papers by this authorKetty Peris
Institute of Dermatology, Catholic University—Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Search for more papers by this author
REFERENCES
- Kelly, G. (2015). Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa. British Journal of Dermatology, 173, 1431–1439.
- Lee, E. (2015). Psoriasis targeted therapy: Characterization of interleukin 17A expression in subtypes of psoriasis. Journal of Drugs in Dermatology, 14(10), 1133–1136.
- Matusiak, Ł. (2017). Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents. Journal of the American Academy of Dermatology, 76, 670–675.
- Puig, L. (2018). Paradoxical reactions: Anti-tumor necrosis factor alpha agents, Ustekinumab, Secukinumab, Ixekizumab, and others. Adverse reactions to biologics. Current Problems in Dermatology, 53, 49–63.
- Singh, R. K. (2016). The role of IL-17 in vitiligo: A review. Autoimmunity Reviews, 15(4), 397–404.
- Speeckaert, R. (2016). The many faces of interleukin-17 in inflammatory skin diseases. British Journal of Dermatology, 175(5), 892–901.
- Toussirot, É. (2016). Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: An analytical and comprehensive overview. RMD Open, 2, e000239.
